"No patients met the primary endpoint of complete PSA response; however, 4/19 (21%) patients had a PSA decline >50%. Median PSA doubling times were 5.9 months pretreatment, 25.6 months on-treatment (p=0.001), and 9.0 months in the subsequent year off-treatment. The overall median radiographic progression-free survival was not reached. "
I like it, but not too much: Phase 2 ... - Advanced Prostate...
I like it, but not too much: Phase 2 trial of a DNA vaccine (pTVG-HP) and nivolumab in patients with nmHSPC
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Shoot..... I keep hearing my echo in here........ Yodeling would be perfect right now.......If I only knew how.......
Note: I wish to offer my apologies if I offended anyone regarding my so-called humor about "race" or "misogyny". To me, humor is boundless and since we entered this word crying, I thought it would be a good idea to exit laughing.
Good Luck, Good Health and Good Humor.
j-o-h-n Sunday 12/17/2023 7:31 PM EST
Not what you're looking for?
You may also like...
Tolerability and treatment response to darolutamide in patients with nmCRPC in the phase III ARAMIS trial
Darolutamide was well tolerated by most patients. Effectiveness related to the PSA decline from...
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen
only 10% of the patients taking curcumin while off ADT for 6 months had PSA progression compared...
New Protocol of Intermittent ADT for Patients With Metastatic PCa
New Chinese study below [1].
"In the 65 metastatic prostate cancer patients in group 1, androgen...
"Early initiation of Lu-177 PSMA radioligand therapy prolongs overall survival in metastatic prostate cancer"
Lu 177 PSMA was effective in prolonging life when used earlier in the disease process....
Diethylstilbestrol when faced with "economic constraint".
New study below [1].
We see so many posts on Zytiga, Xtandi & even more expensive drugs. This...